100% CHM will require a Consolidation
plus
7E.1 Will there be a lead manager or broker to the proposed issue? yes
7E.1a Who is the lead manager/broker?
PAC Partners Securities Pty Ltd Taylor Collison Limited will act as joint lead managers
7E.1b What fee, commission or other consideration is payable to them for acting as lead manager/broker?
6% on offer proceeds
- Forums
- ASX - By Stock
- Ann: $6.6 million Placement to advance clinical trial pipeline
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

100% CHM will require a Consolidation plus 7E.1 Will there be a...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $69.39K | 17.34M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 9474957 | 10 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
40 | 26298938 | 0.003 |
16 | 13800507 | 0.002 |
10 | 50600000 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 9474957 | 10 |
0.005 | 14691167 | 22 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
Last trade - 11.21am 18/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online